The new date is Dec 8, 2021, 12:22pmEST.
New data showing the company's booster shot is a three-dose vaccine series should make Pfizer and BioNTech's Covid-19 vaccine a three-dose vaccine series, according to the company's CEO.
Nurse Mary Ezzat administered a Pfizer COVID-19 booster shot at the UCI Medical Center in Orange, CA.
The Media News Group is a part of the group.
Preliminary lab data shows that a booster shot of the vaccine increases protection against the omicron variant by 25-fold as compared with two shots of the vaccine, though the original two-dose series is believed to still provide protection against severe disease.
When it comes to the omicron variant, it is clear that the Pfizer/BioNTech vaccine should be considered a three-dose vaccine regimen, rather than two shots plus a booster, said Sahin.
The U.S. is the only country that allows Covid-19 booster shots to be administered at least six months after a second dose.
Pfizer and BioNTech said they will continue to study the vaccine's effectiveness in light of omicron after releasing preliminary data.
If it turns out that protection is seriously diminished, they will develop an omicron-specific vaccine.
Moderna has not yet responded to a request for comment regarding whether it still views the company's Covid-19 vaccine as a two-dose or three-dose vaccine series, and the company has not yet released data on its vaccine's effectiveness against omicron.
The vaccine for the omicron variant should be a three-dose vaccine because of the data coming from it, according to Sahin.
What to watch for.
If the definition of fully vaccine is changed from two doses to two plus the booster, it will affect vaccine mandates across the country and exclude those who haven't gotten the booster from public places. Right now, fully vaccination equates to two shots of the J&J and one shot of the mRNA, but without a doubt that could change. That is on the table for discussion, according to Dr. Anthony Fauci.
There is a structure called the Tangent.
Should the vaccine's protection against omicron diminish over time, a second booster shot could be needed. The CEO said the company still had to investigate the question of whether other shots will be necessary through both additional studies and real-world data, and suggested that either vaccine doses specifically tailored to omicron or an additional booster shot might be necessary if effectiveness is shown to diminish as time goes on. Albert Bourla told CNBC Wednesday that he believes we will need a fourth dose of the vaccine sooner than the previous prediction of a year after the booster shot is administered. More data is needed to determine how well the vaccine protects against omicron and how long before making any decisions about additional shots.
The key background.
If you have received a Pfizer, Moderna or Johnson & Johnson vaccine within the last six months, you are eligible for a Covid-19 booster shot. The omicron variant was first detected in southern Africa on November 24 and has since been found in dozens of countries and at least 17 states. There is so far no evidence of how the variant stands up against the shots, even though Pfizer and BioNTech released preliminary data on the variant on Wednesday. Even as it has prompted travel restrictions and other measures worldwide, the new variant of the coronaviruses is still unknown and experts caution more data is needed before any conclusions can be reached.
Companies say that the Pfizer/BioNTech Covid-19 Booster is neutralizing the Omicron variant.
Covid-19 vaccine makers plan to tackle Omicron.
The fourth Covid vaccine may need to be used sooner than expected.
Early reports from the UK, Norway, and South Africa suggest that Omicron variant causes milder covid-19.
Are you fully vaccinated without a booster? The CDC says yes for now.
Coverage and live updates on the coronaviruses.
